Citadel’s Top Equity Holdings Revealed in Latest 13F Filing

Billionaire Ken Griffin's Citadel Advisors disclosed its five largest stock positions in its most recent 13F filing with the SEC. The hedge fund's equity portfolio reflects its technology-driven investment strategy and history of market outperformance.

Charles Schwab leads Citadel's holdings at 1.6% of portfolio weight, followed by the Invesco QQQ Trust ETF tracking the Nasdaq-100 at 1.1%. Medical technology firms Edwards Lifesciences and Medtronic represent the fund's healthcare exposure, accounting for 1% and additional undisclosed portions respectively.

While Citadel's crypto positions remain undisclosed in this filing, the fund's focus on financial services and tech-heavy investments suggests potential indirect exposure to blockchain-adjacent markets. The absence of direct cryptocurrency holdings in this disclosure leaves open questions about institutional adoption patterns among traditional hedge funds.